NCT05606315View on ClinicalTrials.gov

RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

March 16, 2022

Primary Completion Date

March 31, 2024

Study Completion Date

December 31, 2024

Conditions
Remimazolam BesylateSedationICU
Interventions
DRUG

Remimazolam Besylate

NS 50ML + Remimazolam besylate(50mg , 2mg:2ml), IV-Pump,maintenance dose 0.5-3mg/kg/h.

DRUG

Propofol

Propofol (50ml, 0.5g), IV-Pump, maintenance dose 0.3-4.0mg/kg/h.

DRUG

Midazolam

Midazolam (10mg,2ml), IV-Pump, maintenance dose 0.02-0.1mg/kg/h.

Trial Locations (2)

510515

RECRUITING

Southern medical university Nanfang hospital, Guangzhou

518036

NOT_YET_RECRUITING

Peking University Shenzhen Hospital, Shenzhen

All Listed Sponsors
collaborator

Peking University Shenzhen Hospital

OTHER

lead

Nanfang Hospital, Southern Medical University

OTHER